At a glance
ClinicalIndex Comparison RecordN/ACompleted· 256 enrolled
Drug / intervention
EpiCor +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of a Yeast Fermentate (EpiCor) Supplement on Cold or Flu Symptoms in Healthy Children: A Randomized, Double-blind, Placebo Controlled Clinical Trial
In Brief
A clinical study evaluating EpiCor and Placebo for Signs and Symptoms, Respiratory. Completed, enrolled 256 participants across 1 site.
Detailed Summary
This is a double-blind, randomized, placebo-controlled study. The purpose of the clinical study is to determine the difference between 84 days of once daily oral EpiCor supplementation compared to placebo on the incidence of cold or flu symptoms among children aged 4-12 years who are attending school or daycare.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSigns and Symptoms, Respiratory
CountriesCanada
CollaboratorsKGK Science Inc.
Timeline
N/ACompletedFinished
2023202420252026
First PostedAug 2022
Enrollment StartSep 2022
Primary CompletionApr 2023
Study CompletionJul 2023
TodayJul 2026
First PostedAug 8, 2022
Enrollment StartSep 7, 2022
Primary CompletionApr 18, 2023
Study CompletionJul 19, 2023
TodayJul 1, 2026
Enrollment to primary: 7 monthsPosted 3.9 years ago
Interventions
EpiCordietary
2 gummies daily
Placebodietary
2 gummies daily